 |
인쇄하기
취소
|
Patent Court to rule Sanofi-Aventis's Plavix Patent soon
The local patent court will affirm the validity and enforceability of Sanofi-Aventis's Plavix Patent on clopidogrel bisulfate early next month, according to the market sources.
Clopidogrel is the active ingredient in Plavix, the company's treatment for coronary artery disease. The court's decision effectively maintains patent protection for this product in Korea until November 2011.
On Ju...
Clopidogrel is the active ingredient in Plavix, the company's treatment for coronary artery disease. The court's decision effectively maintains patent protection for this product in Korea until November 2011.
On Ju...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.